News Briefing channel feed – Endpoints News

News Briefing channel feed

Incyte hires Janssen exec as CSO Huber moves to Third Rock; Synthorx set terms for $100M IPO

7 years ago

BeiGene inks $60M licensing, research pacts with Zymeworks; Merck, AbbVie, Amgen back neuro upstart

7 years ago

GW Pharma shares surge on positive PhIII followup; Illumina leads $18M round for Stilla's DNA tech

7 years ago

Roivant joins forces with Korea's iNtRON Bio to fight superbugs; Evotec inks deal to leverage AI to develop drugs

7 years ago

Eli Lilly vet takes helm at Brickell Biotech; Stemline's Elzonris secures speedy EU review

7 years ago

Fortress Biotech sells brokerage firm following Reuters exposé; Tracon contends with another setback in brain cancer

7 years ago

Takeda family preps for a last-stand vote against Shire buyout; Eli Lilly reportedly shopping drug portfolio in China

7 years ago

Centrexion delays IPO; Exelixis makes $40M as Cabometyx wins EU nod

7 years ago

Pfizer loses key Lyrica patent battle in the UK; Kleo Pharma closes $21M Series B round

7 years ago

Roche wins speedy FDA review for Tecentriq; South Korean authorities to look into Samsung BioLogics accounting practices

7 years ago

OrbiMed leads $70M raise for Harpoon Therapeutics; Ziopharm inks combo deal with Regeneron's PD-1

7 years ago

BioMarin looks for fast approval of hemophilia A gene therapy; Investigators tout Entasis antibiotic

7 years ago

Shares of Bone Therapeutics dive on PhIII cell therapy failure; GSK-backed Sitryx inks discovery deal

7 years ago

Amgen offers cash and milestones for Provention to take the lead on a celiac drug; Aveo's PhIII fails to impress, shares slide

7 years ago

Regenxbio scores $180M vector deal; Bristol-Myers expands agreement to test Opdivo with Infinity's IPI-549

7 years ago

Kyowa Hakko Kirin gears up to test IDO/PD-1 combo; AbbVie fights Humira biosimilars with 80% price cut in Europe

7 years ago

Vertex wins third CF approval in Europe; ERS Genomics grants DefiniGEN access to CRISPR/Cas9 tech

7 years ago

Tonix jumps on rejigged phase III for PTSD drug; MeiraGTx scores another NIH deal; OpGen, Qiagen join hands to detect superbugs

7 years ago

Roche adds $25M to Halozyme pact for fresh targets; FDA OKs cardio indication for J&J's Invokana

7 years ago

Out to challenge Gilead's daily pills, Viiv scores three-year data on monthly combo; Rigel bags $33M from Asia licensing deal

7 years ago

Biogen, Eisai releases four-year data on aducanumab; EMA stamps Eidos' aTTR therapy with orphan designation

7 years ago

Vertex cleans up its pipeline; FDA grants priority review to Jakafi for GVHD

7 years ago

Our Alzheimer's drug was not a complete bust, says vTv; Xtalpi raises $46M more for AI drug discovery engine

7 years ago

NeoGenomics spends $125M to expand ops; Cara hires Celgene exec as CMO

7 years ago

First page Previous page 55 56 575859 60 61 Next page Last page